BioCentury
ARTICLE | Company News

diaDexus, DGX osteoporosis diagnostic deal

November 21, 2001 8:00 AM UTC

Quest Diagnostics (DGX) exercised an option under a previous deal with diaDexus (South San Francisco, Calif.) to receive an exclusive license in the U.S. and other territories to diaDexus's cathepsin ...